Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry

• Published in: Analytical chemistry (Washington) 2020-11, Vol.92 (22), p.15096-15103
• Main Authors: Larson, Eli J, Zhu, Yanlong, Wu, Zhijie, Chen, Bifan, Zhang, Zhaorui, Zhou, Shiyue, Han, Linjie, Zhang, Qunying, Ge, Ying
• Format: Article
• Language: English
• Subjects: Analytical chemistry; Antibodies; Chains; Chemistry; Chromatography, Liquid - methods; Conjugates; Conjugation; Cyclotron resonance; Cyclotrons; Digestion; Disulfide bonds; Fourier Analysis; Fourier transforms; Heterogeneity; Immunoconjugates - analysis; Immunoconjugates - chemistry; Ions; Isomerism; Isomers; Liquid chromatography; Localization; Mass spectrometry; Mass spectroscopy; Monoclonal antibodies; Resonance; Sample preparation; Scientific imaging; Spectroscopy; Tandem Mass Spectrometry - instrumentation; Time Factors
• ISSN: 0003-2700; 1520-6882
• DOI: 10.1021/acs.analchem.0c03152

Antibody drug conjugates (ADCs), which harness the high targeting specificity of monoclonal antibodies (mAb) with the potency of small molecule therapeutics, are one of the fastest growing pharmaceutical classes. Nevertheless, ADC conjugation techniques and processes may introduce intrinsic heterogeneity including primary sequence variants, varied drug-to-antibody ratio (DAR) species, and drug positional isomers, which must be monitored to ensure the safety and efficacy of ADCs. Liquid chromatography coupled to mass spectrometry (LC-MS) is a powerful tool for characterization of ADCs. However, the conventional bottom-up MS analysis workflows require an enzymatic digestion step which can be time consuming and may introduce artifactual modifications. Herein, we develop an online LC-MS/MS method for rapid analysis of reduced ADCs without digestion, enabling determination of DAR, characterization of the primary sequence, and localization of the drug conjugation site of the ADC using high-resolution Fourier transform ion cyclotron resonance (FTICR) MS. Specifically, a model cysteine-linked ADC was reduced to generate six unique subunits: light chain (Lc) without drug (Lc0), Lc with 1 drug (Lc1), heavy chain (Hc) without drug (Hc0), and Hc with 1–3 drugs (Hc1–3, respectively). A concurrent reduction strategy is applied to assess ADC subunits in both the partially reduced (intrachain disulfide bonds remain intact) and fully reduced (all disulfide bonds are cleaved) forms. The entire procedure including the sample preparation and LC-MS/MS takes less than 55 min, enabling rapid multiattribute analysis of ADCs.